Alembic Pharmaceuticals
-
Alembic Pharma receives USFDA approval for Chlorthalidone tabs USP, 25 mg and 50 mg
Diuretics such as chlorthalidone are indicated in the management of hypertension Alembic Pharmaceuticals has received final approval from the US…
Read More » -
Alembic Pharma receives US FDA tentative approval for Dasatinib tabs
Dasatinib tablets have an estimated market size of $1465 million Alembic Pharmaceuticals has received tentative approval from the US Food…
Read More » -
Alembic Pharma bags US FDA approval for Arformoterol Tartrate Inhalation Solution
The solution is indicated for maintenance treatment of bronchoconstriction in patients with COPD Alembic Pharmaceuticals has received final approval from…
Read More » -
Aleor Dermaceuticals receives US FDA approval for Lidocaine, Prilocaine cream
The cream is indicated as a topical anaesthetic for use on normal intact skin for local analgesia and genital mucous…
Read More » -
Alembic Pharma gets US FDA tentative approval for Dabigatran Etexilate Caps
The capsules are indicated for the reduction of risk of stroke and systemic embolism in non-valvular atrial fibrillation in adult…
Read More » -
Alembic Pharma buys full stake in Aleor Dermaceuticals
The amalgamation will integrate business operations and provide impetus to the existing portfolio of Alembic Alembic Pharmaceuticals has acquired the…
Read More » -
Alembic Pharma receives US FDA approval for Fesoterodine Fumarate extended-release tabs
The tablets are indicated for treating adults with symptoms of urge urinary incontinence, urgency, and frequency Alembic Pharmaceuticals has received…
Read More » -
Alembic Pharma receives US FDA approval for Vortioxetine tabs
The drug is indicated for the treatment of the major depressive disorder (MDD) Alembic Pharmaceuticals has received tentative approval from…
Read More » -
Alembic Pharma bags US FDA approval for Doxycycline Hyclate Delayed-Release Tabs
The drug is indicated to reduce the development of drug-resistant bacteria Alembic Pharmaceuticals has received final approval from the US…
Read More » -
Alembic Pharma bags US FDA approval for Dabigatran Etexilate capsules
Dabigatran Etexilate capsules are indicated to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation…
Read More »